Vasgene Therapeutics Inc

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vasgene Therapeutics Inc.The latest application filed is for "treatment of cancers using sephb4-hsa fusion proteins".

Company Profile

2.9.25

Vasgene Therapeutics Inc - Los Angeles CA US
VasGene Therapeutics, Inc. - Agoura Hills CA US
VasGene Therapeutics, Inc. - Sharon Hill PA
Vasgene Therapeutics, Inc. - Los Angeles CA
VasGene Therapeutics, Inc. - Broomall PA
VasGene Therapeutics, Inc. - Sharon Hills PA
VasGene Therapeutics, Inc. - 1929 Zonal Avenue Los Angeles CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
TREATMENT OF CANCERS USING sEphB4-HSA FUSION PROTEINS App 20220249621 - Krasnoperov; Valery	2022-08-11
Ephb4-ephrin B2 Receptor Ligand Pair As A Novel Marker For The Treatment Of Prostate Cancer App 20220153791 - Krasnoperov; Valery	2022-05-19
Polypeptide compounds for inhibiting angiogenesis and tumor growth Grant 9,533,026 - Krasnoperov , et al. January 3, 2	2017-01-03
Cancer treatment using humanized antibodies that bind to EphB4 Grant 8,975,377 - Gill , et al. March 10, 2	2015-03-10
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth App 20140107030 - Krasnoperov; Valery ; et al.	2014-04-17
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth App 20130344075 - Krasnoperov; Valery ; et al.	2013-12-26
Non-immunoglobulin Antigen Binding Scaffolds For Inhibiting Angiogenesis And Tumor Growth App 20120294875 - Gill; Parkash	2012-11-22
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth App 20120277162 - Krasnoperov; Valery ; et al.	2012-11-01
Polypeptide compounds for inhibiting angiogenesis and tumor growth Grant 8,273,858 - Krasnoperov , et al. September 25, 2	2012-09-25
Polypeptide compounds for inhibiting angiogenesis and tumor growth Grant 8,063,183 - Krasnoperov , et al. November 22, 2	2011-11-22
Methods For Using And Identifying Modulators Of Delta-like 4 App 20110213127 - Gill; Parkash ; et al.	2011-09-01
Polypeptide compounds for inhibiting angiogenesis and tumor growth Grant 7,977,463 - Krasnoperov , et al. July 12, 2	2011-07-12
Polypeptide Compounds For Inhibiting Angiogenesis And Tumor Growth App 20110129482 - Krasnoperov; Valery ; et al.	2011-06-02
Non-immunoglobulin Antigen Binding Scaffolds For Inhibiting Angiogenesis And Tumor Growth App 20110009323 - Gill; Parkash	2011-01-13
Polypeptide compounds for inhibiting angiogenesis and tumor growth Grant 7,862,816 - Krasnoperov , et al. January 4, 2	2011-01-04
Methods And Compositons For Antisense Vegf Oligonucleotides App 20100330152 - Gill; Parkash ; et al.	2010-12-30
Polypeptide compounds for inhibiting angiogenesis and tumor growth App 20100261653 - Krasnoperov; Valery ; et al.	2010-10-14
Nucleic Acid Compounds For Inhibiting Angiogenesis And Tumor Growth App 20100093831 - Reddy; Ramachandra ; et al.	2010-04-15
Nucleic acid compounds for inhibiting angiogenesis and tumor growth Grant 7,585,967 - Reddy , et al. September 8, 2	2009-09-08
Cancer treatment using humanized antibodies that bind to EphB4 App 20090196880 - Gill; Parkash ; et al.	2009-08-06
Polypeptide compounds for inhibiting angiogenesis and tumor growth App 20090155251 - Krasnoperov; Valery ; et al.	2009-06-18
Methods for using and identifying modulators of Delta-like 4 App 20090035308 - Gill; Parkash ; et al.	2009-02-05
Polypeptide Compounds for Inhibiting Angiogenesis and Tumor Growth App 20080131436 - Krasnoperov; Valery ; et al.	2008-06-05
Polypeptide compounds for inhibiting angiogenesis and tumor growth Grant 7,381,410 - Krasnoperov , et al. June 3, 2	2008-06-03
Use of ephrinb2 directed agents for the treatment or prevention of viral infections App 20070218061 - Gill; Parkash ; et al.	2007-09-20
Methods for using and identifying modulators of Delta-like 4 App 20070213266 - Gill; Parkash ; et al.	2007-09-13
Polypeptide compounds for inhibiting angiogenesis and tumor growth App 20070031435 - Krasnoperov; Valery ; et al.	2007-02-08
Polypeptide compounds for inhibiting angiogenesis and tumor growth App 20060204512 - Krasnoperov; Valery ; et al.	2006-09-14
Compositions and methods for detecting and treating tumors App 20060194220 - Reddy; Ramachandra ; et al.	2006-08-31
Polypeptide compounds for inhibiting angiogenesis and tumor growth App 20050249736 - Krasnoperov, Valery ; et al.	2005-11-10
Nucleic acid compounds for inhibiting angiogenesis and tumor growth App 20050164965 - Reddy, Ramachandra ; et al.	2005-07-28
Polypeptide compounds for inhibiting angiogenesis and tumor growth App 20050084873 - Krasnoperov, Valery ; et al.	2005-04-21

Company Registrations

NCAGE Code	67S52	VASGENE THERAPEUTICS, INC.
CAGE Code	67S52	VASGENE THERAPEUTICS, INC.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.